Postoperative antibiotic prophylaxis for implant-based breast reconstruction with acellular dermal Matrix

Yash J. Avashia, Raja Mohan, ChiChi Berhane, John C. Oeltjen

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

BACKGROUND:: The use of acellular dermal matrix in implant-based breast reconstruction has been described for improving inferolateral prosthesis coverage and support and inframammary fold reconstruction. Recommended guidelines for infection prophylaxis are the same as for any clean procedure - antibiotic administration only before surgery. Previous studies have demonstrated increased postoperative rates of infection and seroma associated with the use of acellular dermal matrix. The authors evaluated the impact of postoperative antibiotic prophylaxis on infection rates in postmastectomy expander-based breast reconstruction with acellular dermal matrix. METHODS:: A retrospective study reviewed data of 96 patients who underwent either immediate or delayed expander-based breast reconstruction using AlloDerm allogenic acellular dermal matrix. Infection rates were analyzed after patients received postoperative antibiotic prophylaxis for at least 48 hours compared with those who received only perioperative antibiotics. RESULTS:: Infection rates for breast reconstructions with a postoperative antibiotic course were 7.9 and 3.2 percent. Patients with only perioperative antibiotics had an infection rate of 31.6 percent. Infections were defined by the endpoint of implant removal. Patient demographics, comorbidities, and intraoperative variables were recorded. Uncontrolled variables were time course between mastectomy and reconstruction, nodal dissection, operative history, and whether reconstruction was unilateral or bilateral. CONCLUSIONS:: This study demonstrates significant differences in the rate of infection between the groups of patients undergoing the first stage of two-stage implant-based breast reconstruction who received postoperative antibiotic prophylaxis and the group that received only perioperative antibiotics. This study suggests that the optimal duration of postoperative antibiotic prophylaxis is at least 48 hours. CLINICAL QUESTION/LEVEL OF EVIDENCE:: Therapeutic, III.

Original languageEnglish
Pages (from-to)453-461
Number of pages9
JournalPlastic and Reconstructive Surgery
Volume131
Issue number3
DOIs
StatePublished - Mar 1 2013

Fingerprint

Acellular Dermis
Antibiotic Prophylaxis
Mammaplasty
Infection
Anti-Bacterial Agents
Seroma
Mastectomy
Prostheses and Implants
Dissection
Comorbidity
Retrospective Studies
History
Demography
Guidelines

ASJC Scopus subject areas

  • Surgery

Cite this

Postoperative antibiotic prophylaxis for implant-based breast reconstruction with acellular dermal Matrix. / Avashia, Yash J.; Mohan, Raja; Berhane, ChiChi; Oeltjen, John C.

In: Plastic and Reconstructive Surgery, Vol. 131, No. 3, 01.03.2013, p. 453-461.

Research output: Contribution to journalArticle

Avashia, Yash J. ; Mohan, Raja ; Berhane, ChiChi ; Oeltjen, John C. / Postoperative antibiotic prophylaxis for implant-based breast reconstruction with acellular dermal Matrix. In: Plastic and Reconstructive Surgery. 2013 ; Vol. 131, No. 3. pp. 453-461.
@article{638e8d0b5e534c219e8ab415da2dcb89,
title = "Postoperative antibiotic prophylaxis for implant-based breast reconstruction with acellular dermal Matrix",
abstract = "BACKGROUND:: The use of acellular dermal matrix in implant-based breast reconstruction has been described for improving inferolateral prosthesis coverage and support and inframammary fold reconstruction. Recommended guidelines for infection prophylaxis are the same as for any clean procedure - antibiotic administration only before surgery. Previous studies have demonstrated increased postoperative rates of infection and seroma associated with the use of acellular dermal matrix. The authors evaluated the impact of postoperative antibiotic prophylaxis on infection rates in postmastectomy expander-based breast reconstruction with acellular dermal matrix. METHODS:: A retrospective study reviewed data of 96 patients who underwent either immediate or delayed expander-based breast reconstruction using AlloDerm allogenic acellular dermal matrix. Infection rates were analyzed after patients received postoperative antibiotic prophylaxis for at least 48 hours compared with those who received only perioperative antibiotics. RESULTS:: Infection rates for breast reconstructions with a postoperative antibiotic course were 7.9 and 3.2 percent. Patients with only perioperative antibiotics had an infection rate of 31.6 percent. Infections were defined by the endpoint of implant removal. Patient demographics, comorbidities, and intraoperative variables were recorded. Uncontrolled variables were time course between mastectomy and reconstruction, nodal dissection, operative history, and whether reconstruction was unilateral or bilateral. CONCLUSIONS:: This study demonstrates significant differences in the rate of infection between the groups of patients undergoing the first stage of two-stage implant-based breast reconstruction who received postoperative antibiotic prophylaxis and the group that received only perioperative antibiotics. This study suggests that the optimal duration of postoperative antibiotic prophylaxis is at least 48 hours. CLINICAL QUESTION/LEVEL OF EVIDENCE:: Therapeutic, III.",
author = "Avashia, {Yash J.} and Raja Mohan and ChiChi Berhane and Oeltjen, {John C.}",
year = "2013",
month = "3",
day = "1",
doi = "10.1097/PRS.0b013e31827c6d90",
language = "English",
volume = "131",
pages = "453--461",
journal = "Plastic and Reconstructive Surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Postoperative antibiotic prophylaxis for implant-based breast reconstruction with acellular dermal Matrix

AU - Avashia, Yash J.

AU - Mohan, Raja

AU - Berhane, ChiChi

AU - Oeltjen, John C.

PY - 2013/3/1

Y1 - 2013/3/1

N2 - BACKGROUND:: The use of acellular dermal matrix in implant-based breast reconstruction has been described for improving inferolateral prosthesis coverage and support and inframammary fold reconstruction. Recommended guidelines for infection prophylaxis are the same as for any clean procedure - antibiotic administration only before surgery. Previous studies have demonstrated increased postoperative rates of infection and seroma associated with the use of acellular dermal matrix. The authors evaluated the impact of postoperative antibiotic prophylaxis on infection rates in postmastectomy expander-based breast reconstruction with acellular dermal matrix. METHODS:: A retrospective study reviewed data of 96 patients who underwent either immediate or delayed expander-based breast reconstruction using AlloDerm allogenic acellular dermal matrix. Infection rates were analyzed after patients received postoperative antibiotic prophylaxis for at least 48 hours compared with those who received only perioperative antibiotics. RESULTS:: Infection rates for breast reconstructions with a postoperative antibiotic course were 7.9 and 3.2 percent. Patients with only perioperative antibiotics had an infection rate of 31.6 percent. Infections were defined by the endpoint of implant removal. Patient demographics, comorbidities, and intraoperative variables were recorded. Uncontrolled variables were time course between mastectomy and reconstruction, nodal dissection, operative history, and whether reconstruction was unilateral or bilateral. CONCLUSIONS:: This study demonstrates significant differences in the rate of infection between the groups of patients undergoing the first stage of two-stage implant-based breast reconstruction who received postoperative antibiotic prophylaxis and the group that received only perioperative antibiotics. This study suggests that the optimal duration of postoperative antibiotic prophylaxis is at least 48 hours. CLINICAL QUESTION/LEVEL OF EVIDENCE:: Therapeutic, III.

AB - BACKGROUND:: The use of acellular dermal matrix in implant-based breast reconstruction has been described for improving inferolateral prosthesis coverage and support and inframammary fold reconstruction. Recommended guidelines for infection prophylaxis are the same as for any clean procedure - antibiotic administration only before surgery. Previous studies have demonstrated increased postoperative rates of infection and seroma associated with the use of acellular dermal matrix. The authors evaluated the impact of postoperative antibiotic prophylaxis on infection rates in postmastectomy expander-based breast reconstruction with acellular dermal matrix. METHODS:: A retrospective study reviewed data of 96 patients who underwent either immediate or delayed expander-based breast reconstruction using AlloDerm allogenic acellular dermal matrix. Infection rates were analyzed after patients received postoperative antibiotic prophylaxis for at least 48 hours compared with those who received only perioperative antibiotics. RESULTS:: Infection rates for breast reconstructions with a postoperative antibiotic course were 7.9 and 3.2 percent. Patients with only perioperative antibiotics had an infection rate of 31.6 percent. Infections were defined by the endpoint of implant removal. Patient demographics, comorbidities, and intraoperative variables were recorded. Uncontrolled variables were time course between mastectomy and reconstruction, nodal dissection, operative history, and whether reconstruction was unilateral or bilateral. CONCLUSIONS:: This study demonstrates significant differences in the rate of infection between the groups of patients undergoing the first stage of two-stage implant-based breast reconstruction who received postoperative antibiotic prophylaxis and the group that received only perioperative antibiotics. This study suggests that the optimal duration of postoperative antibiotic prophylaxis is at least 48 hours. CLINICAL QUESTION/LEVEL OF EVIDENCE:: Therapeutic, III.

UR - http://www.scopus.com/inward/record.url?scp=84875027138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875027138&partnerID=8YFLogxK

U2 - 10.1097/PRS.0b013e31827c6d90

DO - 10.1097/PRS.0b013e31827c6d90

M3 - Article

C2 - 23446560

AN - SCOPUS:84875027138

VL - 131

SP - 453

EP - 461

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

SN - 0032-1052

IS - 3

ER -